Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
29
×
venture capital
29
×
life sciences
national blog main
boston blog main
national top stories
startups
boston top stories
san diego blog main
san francisco blog main
texas blog main
vc
new york blog main
san diego top stories
texas top stories
raleigh-durham blog main
cancer
fda
funding
indiana blog main
san francisco top stories
seattle blog main
boulder/denver blog main
clinical trials
deals
detroit blog main
ipo
new york top stories
raleigh-durham top stories
wisconsin blog main
boulder/denver top stories
detroit top stories
indiana top stories
national
seattle top stories
wisconsin top stories
boston
investing
financing
medical devices
What
new
bio
roundup
medicine
san
drugs
health
ipo
life
million
companies
investors
medicines
patients
plans
raised
research
science
advance
capital
developing
device
drug
healthcare
help
innovation
medical
partners
sciences
startups
venture
years
antonio
better
billions
biology
blood
cancer
center
ceo
Language
unset
Current search:
biotech
×
" venture capital "
×
@techcrunch.com
2 years ago
8 cannabis investors share their outlook on the European market in H1 2022
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@techcrunch.com
4 years ago
What tech gets right about healthcare
@xconomy.com
4 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@techcrunch.com
4 years ago
What top VCs look for in women’s fertility startups
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
TMC’s Halvorsen Exits Innovation Institute in Houston
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@techcrunch.com
5 years ago
China is funding the future of American biotech
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
6 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs